RE: Comparative effectiveness of neoadjuvant therapy for HER2-positive breast cancer: a network meta-analysis

J Natl Cancer Inst. 2015 Mar 3;107(4):djv038. doi: 10.1093/jnci/djv038. Print 2015 Apr.

Authors

Xiaolong Qi¹, Li-Juan Ji¹, Xiaoshen Zhang¹, Yuxia Ma¹, Wang Ma¹

Affiliation

¹ Department of Oncology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China (XQ, WM); Tongji University School of Medicine, Shanghai, China (XQ, XZ); Department of Rehabilitation, the Second People's Hospital of Huai'an, Huai'an, China (LJJ); Department of Internal Medicine, Cangzhou Central Hospital, Cangzhou,China (YM).

PMID: 25739417
DOI: 10.1093/jnci/djv038

No abstract available

Publication types

Letter
Comment

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Biomarkers, Tumor / antagonists & inhibitors*
Breast Neoplasms / chemistry*
Breast Neoplasms / drug therapy*
Female
Humans
Neoadjuvant Therapy / methods*
Receptor, ErbB-2 / antagonists & inhibitors*

Substances

Biomarkers, Tumor
Receptor, ErbB-2